China SXT Pharmaceuticals Ownership 2024 | Who Owns China SXT Pharmaceuticals Now?
Institutional Ownership
0.04%
Insider Ownership
6.47%
Retail Ownership
93.49%
Institutional Holders
5.00
China SXT Pharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC | 4.11% | 0.00% | 105,039 | 59,519 | 130.75% | 28,000 | Mar 31, 2023 |
VIRTU FINANCIAL LLC | 1.54% | 0.00% | 39,427 | -49,730 | -55.78% | 11,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 1.35% | - | 34,500 | 34,500 | 100.00% | 10,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.95% | - | 24,410 | 24,410 | 100.00% | 7,018,000 | Mar 31, 2023 |
UBS GROUP AG | 0.70% | - | 17,945 | 7,329 | 69.04% | 5,096,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 0.61% | 0.00% | 15,506 | -29,144 | -65.27% | 4,398,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -67,648 | -100.00% | - | Mar 31, 2023 |
China SXT Pharmaceuticals's largest institutional shareholder is ACADIAN ASSET MANAGEMENT LLC, holding 4.11% of the company's total share outstanding, currently valued at $28.00K. The top 10 institutional shareholders own together 9.26% of the company.
Institutional Shareholders by % of Total Assets
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
VIRTU FINANCIAL LLC | 1.54% | 0.00% | 39,427 | -49,730 | -55.78% | 11,000 | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 4.11% | 0.00% | 105,039 | 59,519 | 130.75% | 28,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 0.61% | 0.00% | 15,506 | -29,144 | -65.27% | 4,398,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 1.35% | - | 34,500 | 34,500 | 100.00% | 10,000 | Mar 31, 2023 |
UBS GROUP AG | 0.70% | - | 17,945 | 7,329 | 69.04% | 5,096,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.95% | - | 24,410 | 24,410 | 100.00% | 7,018,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -67,648 | -100.00% | - | Mar 31, 2023 |
The largest China SXT Pharmaceuticals shareholder by % of total assets is VIRTU FINANCIAL LLC. The company owns 39.43K shares of China SXT Pharmaceuticals (SXTC), representing 0.00% of its total assets.
Institutional Buyers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
ACADIAN ASSET MANAGEMENT LLC | 4.11% | 0.00% | 105,039 | 59,519 | 130.75% | 28,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 1.35% | - | 34,500 | 34,500 | 100.00% | 10,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.95% | - | 24,410 | 24,410 | 100.00% | 7,018,000 | Mar 31, 2023 |
UBS GROUP AG | 0.70% | - | 17,945 | 7,329 | 69.04% | 5,096,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 0.61% | 0.00% | 15,506 | -29,144 | -65.27% | 4,398,000 | Mar 31, 2023 |
VIRTU FINANCIAL LLC | 1.54% | 0.00% | 39,427 | -49,730 | -55.78% | 11,000 | Mar 31, 2023 |
MILLENNIUM MANAGEMENT LLC | - | - | - | -67,648 | -100.00% | - | Mar 31, 2023 |
As of Mar 31 2023, China SXT Pharmaceuticals's largest institutional buyer is ACADIAN ASSET MANAGEMENT LLC. The company purchased 59.52K stocks of SXTC, valued at $28.00K.
Institutional Sellers
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | - | - | - | -67,648 | -100.00% | - | Mar 31, 2023 |
VIRTU FINANCIAL LLC | 1.54% | 0.00% | 39,427 | -49,730 | -55.78% | 11,000 | Mar 31, 2023 |
TWO SIGMA SECURITIES, LLC | 0.61% | 0.00% | 15,506 | -29,144 | -65.27% | 4,398,000 | Mar 31, 2023 |
UBS GROUP AG | 0.70% | - | 17,945 | 7,329 | 69.04% | 5,096,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.95% | - | 24,410 | 24,410 | 100.00% | 7,018,000 | Mar 31, 2023 |
RENAISSANCE TECHNOLOGIES LLC | 1.35% | - | 34,500 | 34,500 | 100.00% | 10,000 | Mar 31, 2023 |
ACADIAN ASSET MANAGEMENT LLC | 4.11% | 0.00% | 105,039 | 59,519 | 130.75% | 28,000 | Mar 31, 2023 |
As of Mar 31 2023, China SXT Pharmaceuticals's biggest institutional seller is MILLENNIUM MANAGEMENT LLC. The company sold -67.65K shares of SXTC, valued at -.
Institutional New positions
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
RENAISSANCE TECHNOLOGIES LLC | 1.35% | - | 34,500 | 34,500 | 100.00% | 10,000 | Mar 31, 2023 |
CITADEL ADVISORS LLC | 0.95% | - | 24,410 | 24,410 | 100.00% | 7,018,000 | Mar 31, 2023 |
China SXT Pharmaceuticals's largest new institutional shareholder by number of shares is RENAISSANCE TECHNOLOGIES LLC, purchased 34.50K shares, valued at $10.00K, as of undefined.
Institutional Sold Out
Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
---|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC | - | - | - | -67,648 | -100.00% | - | Mar 31, 2023 |
China SXT Pharmaceuticals's largest sold out institutional shareholder by shares sold is MILLENNIUM MANAGEMENT LLC, sold -67.65K shares, valued at -, as of undefined.
China SXT Pharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
Date | Holdings | Change % |
---|---|---|
31 Dec, 20 | 5 | -44.44% |
30 Sep, 20 | 9 | 12.50% |
30 Jun, 20 | 8 | 33.33% |
31 Mar, 20 | 6 | 50.00% |
31 Dec, 19 | 4 | - |
30 Sep, 19 | 4 | - |
30 Jun, 19 | 4 | 33.33% |
31 Mar, 19 | 3 | - |
As of 31 Dec 20, 5 institutions are holding China SXT Pharmaceuticals's shares, representing a decrease of -44.44% compared to the previous quarter.
Shares Outstanding Trend
Date | Shares Outstanding | Change % |
---|---|---|
31 Dec, 20 | 852,342 | -72.88% |
30 Sep, 20 | 3,142,433 | -28.52% |
30 Jun, 20 | 4,396,295 | 55.53% |
31 Mar, 20 | 2,826,607 | 28.44% |
31 Dec, 19 | 2,200,672 | 5.96% |
30 Sep, 19 | 2,076,945 | 1.47% |
30 Jun, 19 | 2,046,840 | 4690.73% |
31 Mar, 19 | 42,725 | - |
China SXT Pharmaceuticals (SXTC) has 852.34K shares outstanding as of 31 Dec 20, down -72.88% compared to the previous quarter.
Institutional Ownership Trend
Date | Ownership % | Change % |
---|---|---|
31 Dec, 20 | 0.04% | 170.78% |
30 Sep, 20 | 0.16% | 321.69% |
30 Jun, 20 | 0.22% | 1088.38% |
31 Mar, 20 | 0.14% | 1155.04% |
31 Dec, 19 | 0.11% | 1009.14% |
30 Sep, 19 | 0.10% | 678.46% |
30 Jun, 19 | 0.12% | 1842588.46% |
31 Mar, 19 | 0.00% | - |
As of 31 Dec 20, China SXT Pharmaceuticals is held by 0.04% institutional shareholders, representing a 170.78% growth compared to 30 Sep 20.
Institutional Increased Positions Trend
Date | Increased Positions | Change % |
---|---|---|
31 Dec, 20 | 4 | -33.33% |
30 Sep, 20 | 6 | - |
30 Jun, 20 | 6 | - |
31 Mar, 20 | 6 | 100.00% |
31 Dec, 19 | 3 | -25.00% |
30 Sep, 19 | 4 | 33.33% |
30 Jun, 19 | 3 | - |
31 Mar, 19 | 3 | - |
4 institutional shareholders have increased their position in SXTC stock as of 31 Dec 20 compared to 6 in the previous quarter (a -33.33% decrease).
Institutional Reduced Positions Trend
Date | Reduced Positions | Change % |
---|---|---|
31 Dec, 20 | 1 | -50.00% |
30 Sep, 20 | 2 | 100.00% |
30 Jun, 20 | 1 | - |
31 Mar, 20 | - | -100.00% |
31 Dec, 19 | 1 | - |
30 Sep, 19 | - | -100.00% |
30 Jun, 19 | 1 | - |
31 Mar, 19 | - | - |
1 institutional shareholders have reduced their position in SXTC stock as of 31 Dec 20 compared to 2 in the previous quarter (a -50.00% decrease).
All Institutional Ownership Trend Data
Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
---|---|---|---|---|---|---|---|---|---|---|
31 Dec, 20 | 5 | -44.44% | 852,342 | -72.88% | 0.04% | 170.78% | 4 | -33.33% | 1 | -50.00% |
30 Sep, 20 | 9 | 12.50% | 3,142,433 | -28.52% | 0.16% | 321.69% | 6 | - | 2 | 100.00% |
30 Jun, 20 | 8 | 33.33% | 4,396,295 | 55.53% | 0.22% | 1088.38% | 6 | - | 1 | - |
31 Mar, 20 | 6 | 50.00% | 2,826,607 | 28.44% | 0.14% | 1155.04% | 6 | 100.00% | - | -100.00% |
31 Dec, 19 | 4 | - | 2,200,672 | 5.96% | 0.11% | 1009.14% | 3 | -25.00% | 1 | - |
30 Sep, 19 | 4 | - | 2,076,945 | 1.47% | 0.10% | 678.46% | 4 | 33.33% | - | -100.00% |
30 Jun, 19 | 4 | 33.33% | 2,046,840 | 4690.73% | 0.12% | 1842588.46% | 3 | - | 1 | - |
31 Mar, 19 | 3 | - | 42,725 | - | 0.00% | - | 3 | - | - | - |
China SXT Pharmaceuticals Peer Ownership
Ticker | Company |
---|---|
AKAN | Akanda Corp. |
BFRI | Biofrontera Inc. |
QLI | Qilian International Holding Group Limited |
ACOR | Acorda Therapeutics, Inc. |
SBFM | Sunshine Biopharma, Inc. |
GHSI | Guardion Health Sciences, Inc. |
RGC | Regencell Bioscience Holdings Limited |
ALIM | Alimera Sciences, Inc. |
SHPH | Shuttle Pharmaceuticals Holdings, Inc. |
PTPI | Petros Pharmaceuticals, Inc. |
HUGE | FSD Pharma Inc. |
PROC | Procaps Group S.A. |
JUPW | Safety Shot Inc |
LSDI | Lucy Scientific Discovery Inc. |
PRFX | PainReform Ltd. |
SXTC Ownership FAQ
Who Owns China SXT Pharmaceuticals?
China SXT Pharmaceuticals is owned by institutional shareholders (0.04%), insiders (6.47%), and public (93.49%). The largest institutional shareholder of China SXT Pharmaceuticals is ACADIAN ASSET MANAGEMENT LLC (4.11% of total shares) and the top mutual fund owner is (0% of total shares).
Who are the major institutional shareholders of China SXT Pharmaceuticals?
China SXT Pharmaceuticals's major institutional shareholders are ACADIAN ASSET MANAGEMENT LLC, VIRTU FINANCIAL LLC, RENAISSANCE TECHNOLOGIES LLC, CITADEL ADVISORS LLC, and UBS GROUP AG. The top five shareholders own together 8.65% of the company's share outstanding.
How many China SXT Pharmaceuticals shareholders are there?
As of Dec 2020, there are 5 institutional shareholders of China SXT Pharmaceuticals.
What percentage of China SXT Pharmaceuticals is owned by ACADIAN ASSET MANAGEMENT LLC?
ACADIAN ASSET MANAGEMENT LLC owns 105.04K shares of China SXT Pharmaceuticals, representing 4.11% of the company's total shares outstanding, valued at $28K (as of Mar 2023).
What percentage of China SXT Pharmaceuticals is owned by VIRTU FINANCIAL LLC?
As of Mar 2023, VIRTU FINANCIAL LLC holds 39.43K shares of China SXT Pharmaceuticals (SXTC), compromising 1.54% of the company, valued at $11K.
What percentage of China SXT Pharmaceuticals is owned by RENAISSANCE TECHNOLOGIES LLC?
RENAISSANCE TECHNOLOGIES LLC is the third largest holder of China SXT Pharmaceuticals. The company owns 34.5K of the company's shares outstanding (worth $10K).